CONVULEX Gastro-resistant capsule Ref.[27927] Active ingredients: Valproic acid

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria

Product name and form

Convulex 150 mg Capsules.

Pharmaceutical Form
Gastro-resistant capsule, soft. Old-rose coloured, oblong gelatine capsules with enteric coating.

Qualitative and quantitative composition

1 capsule contains: Valproic Acid 150.00 mg

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Valproic acid	Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

List of Excipients
Gelatine Glycerol 85% Dry substance of Karion 83 (70%) Titanium dioxide Red ferric oxide (E 172) Hydrochloric acid Methacrylic acid-ethylacrylate copolymer (1:1)-dispersion 30% Triethyl citrate Macrogol 6000 Glycerol monostearate 44-55 Type II

Pack sizes and marketing

Blister packs:

Upper: PVC/PVDC or PVC-foil
Lower: aluminium foil
Outer box: carton folding box

Pack size: 100, 30

Marketing authorization holder

G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria

Marketing authorization dates and numbers

PL 21597/0004

11 October 1991 / 16 October 1998 / 2 July 2004

Drugs

Drug	Countries
CONVULEX	Austria, Germany, Estonia, Lithuania, Poland, Romania, Turkey, United Kingdom, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.